ArticleStroke (Hoboken, N.J.)2023
COVID-19 Affects Short-Term, But Not 90-Day, Outcome in Patients With Stroke Treated With Mechanical Thrombectomy.
Article in Stroke (Hoboken, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: COVID-19 is associated with an increased stroke risk. Moreover, outcome at discharge was worse in patients with large-vessel occlusion stroke with concomitant COVID-19 receiving endovascular treatment (ET). We aimed to investigate the impact of concomitant COVID-19 on later functional outcome in patients with large-vessel occlusion stroke treated with ET. Methods: We analyzed patients from the GSR-ET (German Stroke Registry-Endovascular Treatment), an observational multicenter registry of patients with large-vessel occlusion stroke receiving ET. Baseline characteristics, procedural parameters, discharge parameters, and functional outcome at 90 days were compared between patients with concomitant COVID-19 and propensity score-matched controls (ratio, 1:4; matched for age, sex, prestroke modified Rankin Scale score, and stroke severity), and multivariable ordinal regression analysis was performed. Results: Among 4010 patients receiving ET between February 2020 and December 2021, 72 (1.8%) had concomitant COVID-19. Compared with 224 matched patients without COVID-19, they (n=56) were more severely affected, with a higher median National Institutes of Health Stroke Scale (NIHSS) score after 24 hours (NIHSS score, 14.5 [interquartile range {IQR}, 9-22] versus 12 [IQR, 6-18.75]; Conclusions: COVID-19 affected short-term, but not 90-day, functional outcome in patients with large-vessel occlusion stroke treated with ET. Hence, ET should not be withheld in patients with concomitant COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.